Reconsideration of Classical Antibiotic Lincomycin: Anti-inflammatory Effect in LPS-stimulated RAW 264.7 Cells
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Since, side effects of antibiotics are frequently emphasized these days, their use is gradually diminishing, and alternative drugs are being developed. We have sought to reintroduce them as raw materials for human health as conventional ‘weapons’ that have been retired after their historical duties. In this study, we investigated the anti-inflammatory effects of lincomycin (LIN), on lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. Our findings show that LIN potently inhibited production of LPS-induced proinflammatory mediators, such as nitric oxide (NO) and prostaglandin E2 (PGE2), without cytotoxicity. Consistent with these findings, LIN strongly decreased protein expression levels of inducible NO synthase (iNOS) and cyclooxygenase (COX-2). Furthermore, LIN reduced pro-inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β. To further elucidate the mechanisms of these inhibitory effects of LIN, we studied LPS-induced IκB-α degradation, and mitogen-activated protein kinase (MAPK) phosphorylation. LIN suppressed downregulation of inhibitory κB (IκB-α) degradation, and the phosphorylation of the c-Jun N-terminal kinase (JNK) pathway. Based on these results, we suggest that LIN may be considered a potential candidate as an anti-inflammatory cosmetic or a medicine for human health.
Abstract
Since, side effects of antibiotics are frequently emphasized these days, their use is gradually diminishing, and alternative drugs are being developed. We have sought to reintroduce them as raw materials for human health as conventional ‘weapons’ that have been retired after their historical duties. In this study, we investigated the anti-inflammatory effects of lincomycin (LIN), on lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. Our findings show that LIN potently inhibited production of LPS-induced proinflammatory mediators, such as nitric oxide (NO) and prostaglandin E2 (PGE2), without cytotoxicity. Consistent with these findings, LIN strongly decreased protein expression levels of inducible NO synthase (iNOS) and cyclooxygenase (COX-2). Furthermore, LIN reduced pro-inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β. To further elucidate the mechanisms of these inhibitory effects of LIN, we studied LPS-induced IκB-α degradation, and mitogen-activated protein kinase (MAPK) phosphorylation. LIN suppressed downregulation of inhibitory κB (IκB-α) degradation, and the phosphorylation of the c-Jun N-terminal kinase (JNK) pathway. Based on these results, we suggest that LIN may be considered a potential candidate as an anti-inflammatory cosmetic or a medicine for human health.
참고문헌 (27)
- Udommethaporn S, "Assessment of anti-TNF-α activities in keratinocytes expressing inducible TNF-α : A novel tool for anti-TNF-αdrug screening", PLoS One, 11, pp.e0159151~ (2016)
- Lapara NJ 3rd, "Suppression of LPS-induced inflammatory responses in acrophages infected with Leishmania", J. Inflamm(Lond), 7, pp.8~ (2010)
- Zhang X, "Methane limit LPS-induced NF-κB", MAPKs signal in macrophages and suppress immune response in mice by enhancing PI3K, GSK-3β-mediated IL-10 expression, pp.Sci. Rep, 2016[DOI]
- Gao HM, "Novel anti-inflammatory therapy for Parkinson's disease", Trends Pharmacol. Sci, 24, pp.395~401 (2003)
- Copeland S, "Acute inflammatory response to endotoxin in mice and humans", Clin. Diagn. Lab. Immunol, 12, pp.60~67 (2005)
- Roos-Engstrand E, "Increased expression of p38 MAPK in human bronchial epithelium after lipopolysaccharide exposure", Eur. Respir. J, 25, pp.797~803 (2005)
- Soromou LW, "Regulation of inflammatory cytokines in lipopolysaccharidestimulated RAW 264. 7 murine macrophage by 7-O-methylnaringenin", Molecules, 17, pp.3574~3585 (2012)
- Yang G, "Inhibition of lipopolysaccharide-induced nitric oxide and prostaglandin E2 production by chlo-roform fraction of Cudrania tricuspidata in RAW 264.7macrophages", BMC Complement. Altern. Med, 12, pp.250~ (2012)
- Gomez I, "The role of prostaglandin E2 in human vascular inflammation", Prostaglandins Leukot. Essent. Fatty Acids, 89, pp.55~63 (2013)
- Lee HJ, "Eutigoside C inhibits the production of inflammatory mediators (NO, PGE2, IL-6) by down-regulating NF-κB and MAP kinase activity in LPS-stimulated RAW 264.7 cells", J. Pharm. Pharmacol, 60, pp.917~924 (2008)
- Kim JB, "Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF-κB inactivation in RAW 264.7 macrophage cells", Biol. Pharm. Bull, 30, pp.2345~2351 (2007)
- Lawrence T, "The nuclear factor NF-κB pathway in inflammation", Cold Spring Harbor Perspect. Biol, 1, pp.a001651~ (2009)
- Tak PP, "NF-κB : a key role in inflammatory diseases", J. Clin. Invest, 107, pp.7~11 (2001)
- Yeom M, "Xanthii fructus inhibits inflammatory responses in LPS-stimulated RAW 264.7 macrophages through suppressing NF-κB and JNK", p38 MAPK, 2015, pp.24, 394~401
- Fang H, "Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP", J. Immunol, 173, pp.360~366 (2004)
- Frazier WJ, "MAPK signaling drives inflammation in LPS-stimulated cardiomyocytes : the route of crosstalk to G-protein-coupled receptors", PLoS One, 7, pp.e50071~ (2012)
- Neuder LE, "Role of p38 MAPK in LPS induced pro-inflammatory cytokine and chemokine gene expression in equine leukocytes", Vet. Immunol. Immunopathol, 294, pp.192~199 (2009)
- MacLeod AJ, "Lincomycin : A new antibiotic active against Staphylococci and other gram-positive cocci : Clinical and Laboratory Studies", Can. Med. Assoc. J, 14, pp.1056~1060 (1964)
- Duncan IB, "Lincomycin in hospital practice", Can. Med. Assoc. J, 93, pp.685~691 (1965)
- Imai Y, "Lincomycin at subinhibitory concentrations potentiates secondary metabolite production by Streptomyces spp", Appl. Environ. Microbiol, 81, pp.3869~3879 (2015)
- Hall IH, "Effects of moxifloxacin in zymogen A or S. aureus stimulated human THP-1 monocytes on the inflammatory process and the spread of infection", Life Sci, 73, pp.2675~2685 (2003)
- Nakano T, "Clindamycin modulates inflammatory-cytokine induction in lipopolysaccharide-stimulated mouse peritoneal macrophages", Antimicrob. Agents Chemother, 47, pp.363~367 (2003)
- Ulich TR, "Intratracheal administration of endotoxin and cytokines. IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation", Am. J. Pathol, 142, pp.1335~1338 (1993)
- Leigh WK, "Effect of lipopolysaccharide and inflammatory cytokines on interleukin-6 production by healthy human gingival fibroblasts", Infect. Immun, 66, pp.608~614 (1998)
- Ramana KV, "Aldose reductase mediates the lipopolysa-ccharideinduced rele-ase of inflammatory mediators in RAW264.7 murine macrophages", J. Biol. Chem, 281, pp.33019~33029 (2006)
- Van Ahn Vo, "Phosphorylation of Akt Mediates Anti-Inflammatory Activity of 1-p-Coumaroyl β-D-Glucoside Against Lipopolysaccharide-Induced Inflammation in RAW264.7 Cells", The Korean Journal of Physiology & Pharmacology, 18(1), pp.79~86 (2014), 대한약리학회
- Xu X, "Punicalagin induces Nrf2", HO-1 expression via upregulation of PI3K, Mediators Inflamm, pp.2015, 2015[DOI]